SCHEMBL2471818

SCHEMBL2471818

C=COCCOc1ccc(C(C)(C)c2ccc(OCCOC=C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.50
PSMB1 P20618 1/20 0.47
PSMB5 P28074 1/20 0.47
PSMB2 P49721 1/20 0.47
KDM4E B2RXH2 9/20 0.47
ALDH1A1 P00352 8/20 0.47
GAA P10253 1/20 0.46
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
TP53 P04637 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
TSHR P16473 2/20 0.44
HIF1A Q16665 2/20 0.44
CYP1A2 P05177 1/20 0.44
PPARG P37231 1/20 0.44
POLB P06746 2/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.42
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1506584 0.95 SMN1; SMN2 (0.46) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL12136354 0.91 SMN1; SMN2 (0.47) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL11789508 0.89 KDM4E (0.49) SMN1; SMN2KDM4EALDH1A1GAAMEN1
SCHEMBL905336 0.89 KDM4E (0.41) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL1506586 0.87 SMN1; SMN2 (0.40) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL16900536 0.87 SMN1; SMN2 (0.40) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL419937 0.84 THRB (0.41) KDM4EALDH1A1MAPTHTTTDP1
SCHEMBL25987621 0.84 TDP1 (0.39) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL1506473 0.84 ALDH1A1 (0.45) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E
SCHEMBL13475860 0.82 SMN1; SMN2 (0.53) SMN1; SMN2PSMB1PSMB5PSMB2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250172877-A1 REVERSIBLE OVERCOAT COMPOSITIONS TOKYO ELECTRON LIMITED (JP) 2025-05-29 US claimed
US-20080045618-A1 Low viscosity UV curable ink formulations COLLINS INK CORPORATION 2008-02-21 US claimed
WO-2008002543-A2 LOW VISCOSITY UV CURABLE INK FORMULATIONS HEXION SPECIALTY CHEMICALS INC. (US) 2008-01-03 WO claimed
US-6395450-B1 MIXTURE OF ACID GENERATOR, BINDER AND SOLVENT SAMSUNG ELECTRONICS CO., LTD. (KR) 2002-05-28 US claimed
US-5194365-A Method for forming images CIBA-GEIGY CORPORATION (US) 1993-03-16 US claimed
US-4617354-A DIVINYL ETHER-MODIFIED OLEFINUNSATURATED CARBOXY-CONTAINING ACID COPOLYMER ATOCHEM (FR) 1986-10-14 US claimed
US-3933509-A Photo-polymerizable composition containing an acid salt of an indolinobenzospiropyran FUJI PHOTO FILM CO., LTD. (JA) 1976-01-20 US claimed
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP disclosed
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia SICPA HOLDING SA (CH) 2026-05-05 US disclosed
EP-4352175-B1 HYBRID UV-LED RADIATION CURABLE PROTECTIVE VARNISHES FOR SECURITY DOCUMENTS SICPA HOLDING SA (CH) 2026-02-25 EP disclosed
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-01-15 US disclosed
US-12515470-B2 UV-Vis radiation curable security inks SICPA HOLDING SA (CH) 2026-01-06 US disclosed
EP-4433547-B1 METHODS FOR PRODUCING OVERT SECURITY FEATURES EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2025-12-24 EP disclosed
US-4744852-A DIVINYL ETHER MODIFIED ETHYLENE, ALKYL ACRYLATE-ACRYLIC ACID TERPOLYMER ATOCHEM (FR) 1988-05-17 US disclosed
US-4705887-A Aromatic polyvinyl ethers and heat curable molding compositions obtained therefrom GENERAL ELECTRIC COMPANY (US) 1987-11-10 US disclosed
EP-0207893-A2 Image-forming process CIBA-GEIGY AG (CH) 1987-01-07 EP disclosed
US-4617354-A DIVINYL ETHER-MODIFIED OLEFINUNSATURATED CARBOXY-CONTAINING ACID COPOLYMER ATOCHEM (FR) 1986-10-14 US disclosed
US-4518788-A Aromatic polyvinyl ethers and heat curable molding compositions obtained therefrom GENERAL ELECTRIC COMPANY (US) 1985-05-21 US disclosed
US-4388450-A THERMAL CURING CATALYSTS, QUICK-SETTING; GENERAL ELECTRIC COMPANY (US) 1983-06-14 US disclosed
US-3933509-A Photo-polymerizable composition containing an acid salt of an indolinobenzospiropyran FUJI PHOTO FILM CO., LTD. (JA) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA IK, TEX10, INCENP SMN1; SMN2 1005/4885PSMB1 1114/4885PSMB5 1897/4885
US-12616995-B2 Methods for producing overt security features exhibiting one or more indicia ATG4B, TPM4, ATG4A SMN1; SMN2 2124/4885PSMB1 741/4885PSMB5 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.